Pathophysiology of Atherosclerosis

Introduction of Pathophysiology of Atherosclerosis

Atherosclerosis is a chronic, progressive inflammatory disease of the arterial wall characterized by the accumulation of lipids, immune cells, and fibrous elements, leading to the formation of atherosclerotic plaques. It underlies most cardiovascular diseases, including coronary artery disease (CAD), cerebrovascular disease, and peripheral artery disease (PAD). Understanding its pathophysiology is essential for identifying therapeutic targets and developing strategies for prevention and treatment.

1. Endothelial Injury and Dysfunction

Initiation Phase

The pathogenesis of atherosclerosis begins with injury to the endothelium, the monolayer of cells lining the blood vessels. The endothelium acts as a barrier and modulator, maintaining vascular tone, inhibiting thrombosis, and regulating immune responses.

Major Causes of Endothelial Injury:

• Hemodynamic stress (e.g., turbulent blood flow at arterial branch points)
• Hypertension (mechanical stress and oxidative damage)
• Hyperlipidemia, especially elevated low-density lipoprotein (LDL) cholesterol
• Smoking (induces oxidative stress and inflammation)
• Diabetes mellitus (via advanced glycation end products and reactive oxygen species)
• Infections and toxins

Once damaged, endothelial cells become dysfunctional, losing their anti-atherogenic properties. This dysfunction results in:

• Increased vascular permeability
• Reduced nitric oxide (NO) availability
• Enhanced expression of adhesion molecules (VCAM-1, ICAM-1, E-selectin)
• Prothrombotic and pro-inflammatory state

2. Lipoprotein Entry and Modification

Following endothelial injury, lipoproteins, particularly LDL particles, begin to accumulate within the subendothelial space of the intima. Due to the oxidative environment, these LDL molecules undergo oxidation to form oxidized LDL (Ox-LDL), a key player in atherogenesis.

Key Processes:

• Retention: LDL binds to proteoglycans in the extracellular matrix of the intima.
• Modification: LDL is oxidized by reactive oxygen species (ROS) and enzymes such as lipoxygenases and myeloperoxidase.
• Chemotactic signaling: Ox-LDL stimulates endothelial cells to secrete chemokines like MCP-1 (monocyte chemoattractant protein-1), further promoting leukocyte recruitment.

Ox-LDL is highly pro-inflammatory and cytotoxic, contributing to immune cell activation and perpetuating local inflammation.

3. Leukocyte Recruitment and Activation

The inflammatory environment created by endothelial dysfunction and Ox-LDL promotes leukocyte recruitment.

Sequence of Events:

• Endothelial cells express adhesion molecules (e.g., VCAM-1, ICAM-1, P-selectin) on their surface.
• Circulating monocytes and T-lymphocytes adhere to these molecules and migrate into the intima.
• Monocytes differentiate into macrophages under the influence of colony-stimulating factors (e.g., M-CSF).

T-cells also infiltrate the lesion and contribute to the chronic inflammatory milieu through cytokine secretion.

4. Foam Cell Formation and Fatty Streaks

Macrophages within the intima engulf Ox-LDL through scavenger receptors (e.g., SR-A, CD36). Unlike normal LDL receptors, scavenger receptors are not downregulated in response to cholesterol accumulation, leading to uncontrolled lipid uptake.

Consequences:

• Formation of foam cells (lipid-laden macrophages)
• Foam cells release pro-inflammatory cytokines (e.g., IL-1β, TNF-α), perpetuating inflammation.
• Accumulation of foam cells creates the “fatty streak”, the earliest visible lesion of atherosclerosis.

Fatty streaks can be found even in children and adolescents and may or may not progress to advanced lesions depending on risk factor exposure.

5. Amplification of Inflammation

Chronic inflammation is central to the progression of atherosclerosis. Activated immune cells (macrophages and T-cells) release a cascade of pro-inflammatory mediators:

• Cytokines: IL-6, TNF-α, IFN-γ
• Chemokines: MCP-1, IL-8
• Growth factors: PDGF, TGF-β

These mediators lead to:

• Further recruitment of immune cells
• Induction of apoptosis in endothelial and smooth muscle cells
• Enhanced oxidative stress, maintaining LDL oxidation

T-helper 1 (Th1) cells dominate the immune response in plaques, promoting pro-inflammatory cytokines and further macrophage activation.

6. Smooth Muscle Cell (SMC) Proliferation and Migration

Inflammatory cytokines and growth factors stimulate the migration of smooth muscle cells (SMCs) from the tunica media into the intima. Once in the intima, SMCs:

• Proliferate under the influence of PDGF and TGF-β
• Synthesize and secrete extracellular matrix (ECM) proteins such as collagen, elastin, and proteoglycans

Role of SMCs:

• Contribute to the fibrous cap formation over the lipid core
• Provide structural stability to the developing plaque

However, SMCs can also engulf lipids and become foam cells, contributing to the necrotic core of advanced plaques.

7. Plaque Formation and Progression

A fully formed atherosclerotic plaque has two main components:

1. Lipid-rich necrotic core: Contains dead foam cells, cholesterol crystals, lipids, and debris
2. Fibrous cap: Composed of collagen, SMCs, and ECM components

Stable vs. Unstable Plaques

• Stable plaques: Thick fibrous cap, small lipid core, low inflammatory cell content; less likely to rupture.
• Unstable plaques: Thin fibrous cap, large lipid core, rich in macrophages and inflammatory cells; prone to rupture.

Progressive plaque growth leads to luminal narrowing, reducing blood flow, and causing ischemia in affected tissues (e.g., angina pectoris in coronary arteries).

8. Plaque Rupture, Thrombosis, and Clinical Events

As plaques enlarge, they become susceptible to complications that result in acute clinical manifestations:

Plaque Destabilization:

• Inflammatory cells secrete matrix metalloproteinases (MMPs), which degrade the collagen in the fibrous cap.
• This weakens the cap and increases the risk of rupture or erosion.
• Exposure of thrombogenic material (e.g., tissue factor, collagen) to the bloodstream triggers platelet activation.

Thrombosis:

• Platelet adhesion, activation, and aggregation occur rapidly.
• Coagulation cascade is activated, leading to fibrin clot formation.
• The thrombus may partially or completely occlude the vessel.

Conclusion

Atherosclerosis is a complex, multi-stage process involving lipid accumulation, immune activation, endothelial dysfunction, and structural remodeling of the arterial wall. While it begins silently, its clinical manifestations—heart attacks, strokes, and sudden death—are often catastrophic. Current research continues to explore the molecular pathways involved, offering hope for improved prevention and treatment strategies.